(NASDAQ: ECOR) Electrocore's forecast annual revenue growth rate of 38.74% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Electrocore's revenue in 2024 is $18,693,000.On average, 2 Wall Street analysts forecast ECOR's revenue for 2024 to be $151,268,728, with the lowest ECOR revenue forecast at $150,271,721, and the highest ECOR revenue forecast at $152,271,741. On average, 2 Wall Street analysts forecast ECOR's revenue for 2025 to be $226,260,443, with the lowest ECOR revenue forecast at $218,020,123, and the highest ECOR revenue forecast at $234,500,763.
In 2026, ECOR is forecast to generate $299,846,739 in revenue, with the lowest revenue forecast at $294,837,682 and the highest revenue forecast at $304,855,797.